Research and Markets (http://www.researchandmarkets.com/research/c793hw/retinitis) has announced the addition of the "Retinitis Pigmentosa (Retinitis)-Pipeline Insights, 2016" report to their offering.
Retinitis Pigmentosa (Retinitis)-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Retinitis Pigmentosa (Retinitis). The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Retinitis Pigmentosa (Retinitis).
The report also assesses the Retinitis Pigmentosa (Retinitis) therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope
The report provides competitive pipeline landscape of Retinitis Pigmentosa (Retinitis)
The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
Coverage of the Retinitis Pigmentosa (Retinitis) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
The report reviews key players involved in the therapeutics development for Retinitis Pigmentosa (Retinitis) and also provide company profiling
The report also gives the information of dormant and discontinued pipeline projects
Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Retinitis Pigmentosa (Retinitis) Overview
- Retinitis Pigmentosa (Retinitis) Pipeline Therapeutics
- Retinitis Pigmentosa (Retinitis) Therapeutics under Development by Companies
- Retinitis Pigmentosa (Retinitis) Filed and Phase III Products
- Comparative Analysis
- Retinitis Pigmentosa (Retinitis) Phase II Products
- Retinitis Pigmentosa (Retinitis) Phase I and IND Filed Products
- Retinitis Pigmentosa (Retinitis) Discovery and Pre-Clinical Stage Products
- Retinitis Pigmentosa (Retinitis) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Retinitis Pigmentosa (Retinitis) - Discontinued Products
- Retinitis Pigmentosa (Retinitis) - Dormant Products
- Companies Involved in Therapeutics Development for Retinitis Pigmentosa (Retinitis)
For more information visit http://www.researchandmarkets.com/research/c793hw/retinitis
View source version on businesswire.com: http://www.businesswire.com/news/home/20160128006078/en/
